Trial intelligence / Profile preview

Clinical pharmacology study of K-877 in dyslipidemia

jRCT2080222359Phase 1

Sponsor
Kowa Company, Ltd.
Start
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in dyslipidemia comparing K-877 with Placebo (2 arms).

02

Drugs

pemafibrate
03

Conditions

dyslipidemia

Beyond the preview

Go deeper on jRCT2080222359.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080222359.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call